Literature DB >> 23677863

Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.

Hema L Ramkumar1, Jingsheng Tuo, De F Shen, Jun Zhang, Xiaoguang Cao, Emily Y Chew, Chi-Chao Chan.   

Abstract

The Age-Related Eye Diseases Study 2 (AREDS2) clinical trial is assessing the effects of higher dietary xanthophyll (lutein and zeaxanthin) and long-chain n3 polyunsaturated fatty acid (LCPUFA) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) intake on progression to advanced age-related macular degeneration (AMD). This study's purpose was to examine the retinal effects of the AREDS2 formulation on Chemokine (C-C motif) ligand 2 (Ccl2(-/-))/CX3C chemokine receptor 1 (Cx3cr1(-/-)) mice on Crumbs homolog 1 retinal degeneration phenotype 8 (Crb1(rd8)) background (DKO), which develop focal retinal lesions with certain features similar to AMD. DKO and C57BL/6N rd8 background mice (WT) were bred and randomized into 4 groups. Two groups, WT mice on AREDS2 diet (A-WT) and DKO mice on AREDS2 diet (A-DKO), were supplemented daily with 1.76 μmol of lutein, 35.1 μmol of zeaxanthin, 215 μmol EPA, and 107 μmol of DHA, and 2 control groups, WT mice on control diet (C-WT) and DKO mice on control diet (C-DKO), were fed an isocaloric diet. All mice had monthly fundus photos and were killed after 3 mo for biochemical and histologic analyses. After 3 mo, 81% of A-DKO mice had lesion regression compared with 25% of C-DKO mice (P < 0.05). Toxic retinal 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E,7E-octatetra-enyl]-1-(2-hydroxyethyl)-4-[4-methyl-6(2,6,6-trimethyl-1-cyclohexen-1-yl) 1E,3E,5E,7E-hexatrienyl]-pyridinium (A2E) concentrations were significantly lower in A-DKO compared with C-DKO mice. The outer nuclear layer thickness in A-DKO mice was significantly greater than that in C-DKO mice. Retinal expression of inducible nitric oxide synthase (iNos) tumor necrosis factor-α (Tnf-α), Cyclooxygenase-2 (Cox-2), interleukin1beta (IL-1β), and vascular endothelial growth factor (Vegf) was significantly lower in A-DKO compared with C-DKO mice. Xanthophylls and LCPUFAs have antiinflammatory, neuroprotective, and antiangiogenic properties. Our data provide potential mechanisms by which the AREDS2 formula has a protective effect on retinal lesions in DKO mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677863      PMCID: PMC3681547          DOI: 10.3945/jn.112.169649

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  51 in total

Review 1.  Review: effects of nitric oxide on eye diseases and their treatment.

Authors:  G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  2001-04       Impact factor: 2.671

2.  Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Authors:  Tomas S Aleman; Artur V Cideciyan; Geoffrey K Aguirre; Wei Chieh Huang; Cristina L Mullins; Alejandro J Roman; Alexander Sumaroka; Melani B Olivares; Frank F Tsai; Sharon B Schwartz; Luk H Vandenberghe; Maria P Limberis; Edwin M Stone; Peter Bell; James M Wilson; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

3.  The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes.

Authors:  Mary J Mattapallil; Eric F Wawrousek; Chi-Chao Chan; Hui Zhao; Jayeeta Roychoudhury; Thomas A Ferguson; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

4.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

5.  Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.

Authors:  Sung Wook Park; Chang Sik Cho; Hyoung Oh Jun; Nam Hee Ryu; Jin Hyoung Kim; Young Suk Yu; Jin Sook Kim; Jeong Hun Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-19       Impact factor: 4.799

6.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

Authors:  Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris
Journal:  Ophthalmology       Date:  2012-07-26       Impact factor: 12.079

7.  Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background.

Authors:  Jun Zhang; Jingsheng Tuo; Xiaoguan Cao; Defen Shen; Wei Li; Chi-Chao Chan
Journal:  Synapse       Date:  2013-05-27       Impact factor: 2.562

8.  Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model.

Authors:  Jingsheng Tuo; Xiaoguang Cao; Defen Shen; Yujuan Wang; Jun Zhang; Joo Youn Oh; Darwin J Prockop; Chi-Chao Chan
Journal:  J Neuroinflammation       Date:  2012-03-27       Impact factor: 8.322

Review 9.  Neuroprotective effects of lutein in the retina.

Authors:  Yoko Ozawa; Mariko Sasaki; Noriko Takahashi; Mamoru Kamoshita; Seiji Miyake; Kazuo Tsubota
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

10.  IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation.

Authors:  Yang Liu; Montserrat Biarnés Costa; Chiara Gerhardinger
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

View more
  24 in total

1.  Animal models of age-related macular degeneration and their translatability into the clinic.

Authors:  Shida Chen; Nicholas A Popp; Chi-Chao Chan
Journal:  Expert Rev Ophthalmol       Date:  2014-07-12

Review 2.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

3.  Wnt signaling in age-related macular degeneration: human macular tissue and mouse model.

Authors:  Jingsheng Tuo; Yujuan Wang; Rui Cheng; Yichao Li; Mei Chen; Fangfang Qiu; Haohua Qian; Defen Shen; Rosana Penalva; Heping Xu; Jian-Xing Ma; Chi-Chao Chan
Journal:  J Transl Med       Date:  2015-10-17       Impact factor: 5.531

Review 4.  Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD).

Authors:  Paulina Tokarz; Kai Kaarniranta; Janusz Blasiak
Journal:  Biogerontology       Date:  2013-09-22       Impact factor: 4.277

5.  NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration.

Authors:  Yujuan Wang; Jakub W Hanus; Mones S Abu-Asab; Defen Shen; Alexander Ogilvy; Jingxing Ou; Xi K Chu; Guangpu Shi; Wei Li; Shusheng Wang; Chi-Chao Chan
Journal:  Int J Mol Sci       Date:  2016-01-08       Impact factor: 5.923

Review 6.  Inflammation and its role in age-related macular degeneration.

Authors:  Anu Kauppinen; Jussi J Paterno; Janusz Blasiak; Antero Salminen; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2016-02-06       Impact factor: 9.261

7.  Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique.

Authors:  Marina Green-Gomez; Paul S Bernstein; Christine A Curcio; Rachel Moran; Warren Roche; John M Nolan
Journal:  Transl Vis Sci Technol       Date:  2019-12-18       Impact factor: 3.283

8.  Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.

Authors:  Alina Adriana Ivanescu; Patricia Fernández-Robredo; Henar Heras-Mulero; Luis Manuel Sádaba-Echarri; Laura García-García; Vanessa Fernández-García; Maite Moreno-Orduna; Aitor Redondo-Exposito; Sergio Recalde; Alfredo García-Layana
Journal:  Nutrients       Date:  2015-07-06       Impact factor: 5.717

9.  Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions.

Authors:  Nicholas Popp; Xi K Chu; Defen Shen; Jingsheng Tuo; Chi-Chao Chan
Journal:  J Clin Exp Ophthalmol       Date:  2013-10-01

10.  Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration.

Authors:  Yujuan Wang; Preeti Subramanian; Defen Shen; Jingsheng Tuo; S Patricia Becerra; Chi-Chao Chan
Journal:  ASN Neuro       Date:  2013-11-26       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.